Literature DB >> 28380387

Metabolite quantification by NMR and LC-MS/MS reveals differences between unstimulated, stimulated, and pure parotid saliva.

João Figueira1, Sandra Gouveia-Figueira2, Carina Öhman3, Pernilla Lif Holgerson3, Malin L Nording4, Anders Öhman5.   

Abstract

Saliva is a readily available biofluid that is sensitive to metabolic changes and can be collected through rapid and non-invasive collection procedures, and it shows great promise for clinical metabolomic studies. This work studied the metabolite composition of, and the differences between, saliva samples collected by unstimulated spitting/drooling, paraffin chewing-stimulated spitting, and parotid gland suction using targeted nuclear magnetic resonance (NMR) spectroscopy and liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) for metabolite quantification. As applied here, these two analytical techniques provide complementary metabolite information and together extend the metabolome coverage with robust NMR quantification of soluble metabolites and sensitive targeted LC-MS/MS analysis of bioactive lipids in specific metabolic pathways. The NMR analysis was performed on ultrafiltrated (3kDa cutoff) saliva samples and resulted in a total of 45 quantified metabolites. The LC-MS/MS analysis was performed on both filtered and unfiltered samples and resulted in the quantification of two endocannabinoids (AEA and PEA) and 22 oxylipins, which at present is the most comprehensive targeted analysis of bioactive lipids in human saliva. Important differences in the metabolite composition were observed between the three saliva sample collection methods, which should be taken into consideration when designing metabolomic studies of saliva. Furthermore, the combined use of the two metabolomics platforms (NMR and LC-MS/MS) proved to be viable for research and clinical studies of the salivary metabolome.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Eicosanoids; Endocannabinoids; LC-MS/MS; NMR; Oxylipins; Saliva

Mesh:

Year:  2017        PMID: 28380387     DOI: 10.1016/j.jpba.2017.03.037

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

1.  Metabolomics technology and bioinformatics for precision medicine.

Authors:  Rajeev K Azad; Vladimir Shulaev
Journal:  Brief Bioinform       Date:  2019-11-27       Impact factor: 11.622

2.  Development of analytical methods to study the salivary metabolome: impact of the sampling.

Authors:  Pauline Bosman; Valérie Pichon; Ana Carolina Acevedo; Hélène Chardin; Audrey Combes
Journal:  Anal Bioanal Chem       Date:  2022-08-05       Impact factor: 4.478

Review 3.  Salivary Metabolomics for Oral Cancer Detection: A Narrative Review.

Authors:  Karthika Panneerselvam; Shigeo Ishikawa; Rajkumar Krishnan; Masahiro Sugimoto
Journal:  Metabolites       Date:  2022-05-12

Review 4.  Minimally Invasive Biospecimen Collection for Exposome Research in Children's Health.

Authors:  Lauren M Petrick; Manish Arora; Megan M Niedzwiecki
Journal:  Curr Environ Health Rep       Date:  2020-09

Review 5.  Salivary Metabolomics: From Diagnostic Biomarker Discovery to Investigating Biological Function.

Authors:  Alexander Gardner; Guy Carpenter; Po-Wah So
Journal:  Metabolites       Date:  2020-01-26

6.  Determining bacterial and host contributions to the human salivary metabolome.

Authors:  Alexander Gardner; Harold G Parkes; Po-Wah So; Guy H Carpenter
Journal:  J Oral Microbiol       Date:  2019-06-04       Impact factor: 5.474

7.  Comparison of oral metabolome profiles of stimulated saliva, unstimulated saliva, and mouth-rinsed water.

Authors:  Yuki Maruyama; Yuichiro Nishimoto; Kouta Umezawa; Ryosuke Kawamata; Yuko Ichiba; Kota Tsutsumi; Mitsuo Kimura; Shinnosuke Murakami; Yasushi Kakizawa; Takashi Kumagai; Takuji Yamada; Shinji Fukuda
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.379

8.  Salivary inflammatory mediators as biomarkers for oral mucositis and oral mucosal dryness in cancer patients: A pilot study.

Authors:  Anna Kiyomi; Kensuke Yoshida; Chie Arai; Risa Usuki; Kyosuke Yamazaki; Naoto Hoshino; Akira Kurokawa; Shinobu Imai; Naoto Suzuki; Akira Toyama; Munetoshi Sugiura
Journal:  PLoS One       Date:  2022-04-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.